Keyword Connections

fingolimod

Journals

3

1 value in health regional issues

2 Journal of the neurological sciences

3 pharmacology & therapeutics

Research Groups

0

No Research Group Connected

Bibliographies

16

1 Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target.

2 Fingolimod for the treatment of multiple sclerosis in French West Indies, a real-world study in patients from African ancestry.

3 Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia.

4 the outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: a longitudinal study in an iranian population

5 leprosy mimicking basal cell carcinoma in a patient on fingolimod

6 Dual dose-dependent effects of fingolimod in a mouse model of Alzheimer’s disease

7 Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies.

8 Fingolimod downregulates brain sphingosine-1-phosphate receptor 1 levels but does not promote remyelination or neuroprotection in the cuprizone model

9 Correction to: Analysis of cardiac monitoring and safety data in patients initiating fingolimod treatment in the home or in clinic.

10 A systematic evaluation of the safety and toxicity of fingolimod for its potential use in the treatment of acute myeloid leukaemia.

11 Annualized hospitalization rate with natalizumab vs fingolimod in second-line treatment for RRMS in the public healthcare system in Brazil: A claim database approach.

12 Is antibody titer useful to verify the immunization after VZV Vaccine in MS patients treated with Fingolimod? A case series

13 fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

14 fingolimod: the first oral drug approved by food and drug administration; a breakthrough in treatment of multiple sclerosis

15 efectos cardiovasculares de fingolimod en el tratamiento de la esclerosis múltiple

16 a cross-sectional survey of patient satisfaction and subjective experiences of treatment with fingolimod